Researchers from the Indian Institute of Technology, Madras, have figured out how the compound responsible for chilis' heat kills prostate cancer cells.
The findings suggest that the chili compound capsaicin could one day be used to develop effective anti-cancer drugs in the form of an injection or pill.
In this study, researchers Ashok Kumar Mishra and Jitendriya Swain found that in high doses the compound causes cell membranes to come apart.
About 10 years ago, researchers reported that capsaicin can kill prostate cancer cells in mice while leaving healthy cells unharmed.
But translating that dose to humans would require them to eat a huge number of chili peppers per day.
So the researchers tried to gain a deeper understanding of capsaicin's effects so it might be harnessed in the future for new medicines.
The scientists were able to detect how the compound interacts with cell membranes by monitoring its natural fluorescence.
The study showed that capsaicin lodges in the membranes near the surface. Add enough of it, and the capsaicin essentially causes the membranes to come apart.
The findings appeared in The Journal of Physical Chemistry B.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
